Small Caps Test Their 200-Day Line as Yields Grind Higher and Earnings Season Stirs
SAN FRANCISCO, Oct. 01, 2026 (GLOBE NEWSWIRE) -- USA Newsroom News Commentary - This has been a week of slow leaks
Press Release Disclaimer: This is a press release distributed through the XPR Media network. It has not been independently verified by our newsroom.

![]()
SAN FRANCISCO, Oct. 01, 2026 (GLOBE NEWSWIRE) — USA Newsroom News Commentary – This has been a week of slow leaks rather than blowouts for U.S. stocks. As of midday Thursday, the Dow Jones Industrial Average, the S&P 500, the Nasdaq Composite and the Russell 2000 were all lower for the week, with small caps taking the hardest hit as the 10-year Treasury yield climbed 6 basis points on the week to 5.24%, according to the latest edition of The Roadmap from Stock Preachers. At the same time, a fresh batch of company results is starting to show which businesses are protecting their margins in a tougher cost environment. Active companies with developments this week include: McCormick & Company, Incorporated (NYSE: MKC), Conagra Brands, Inc. (NYSE: CAG), WTW (Nasdaq: WTW), RedHill Biopharma Ltd. (Nasdaq: RDHL), and Recon Technology, Ltd (Nasdaq: RCON).
By the midday numbers, the Dow sat at 50,850.02, down 1.89% for the week but still up 5.8% on the year. The S&P 500 was at 7,648.36, off 1.23% this week with an 11.73% year-to-date gain intact, while the Nasdaq Composite held at 26,821.12, down 0.91% for the week and up 15.4% for the year. The Russell 2000 was the laggard at 2,800.92, down 1.29% since last Friday, and its 14-day RSI of 30.9 was the lowest of the four, a sign that small caps have absorbed the brunt of the selling.
The levels now in play are close at hand. The Russell 2000 is testing its 200-day simple moving average at 2,780.01, the S&P 500 is parked just below its 50-day SMA at 7,650.99, and the Dow is holding above its 200-day SMA near 50,260.45. Volatility has firmed as well: the VIX was at 16.95 and the Nasdaq-100 volatility gauge, the VXN, was at 23.13, up 2.26 points for the week, suggesting traders are paying up for protection in tech and growth names. The full support and resistance ladders for all four major indices are laid out in The Roadmap.
CONTINUED… Read this and more, including the week’s leaders and laggards and the levels to watch into next week, at Stock Preachers: https://stockpreachers.com/articles/a-choppy-week-leaves-the-tape-looking-for-footing/
In other company developments and happenings in the market this week:
McCormick & Company, Incorporated (NYSE: MKC) reported third quarter results and reaffirmed its fiscal 2026 outlook. The company said net sales increased 17.4%, with organic sales growth of 1.9%, and that gross profit margin expanded by 190 basis points versus the prior year. Earnings per share was $0.36 compared with $0.84 a year earlier, while adjusted earnings per share was $0.86 compared with $0.85.
McCormick also said it remains on track with integration planning for the proposed Unilever Foods combination. “Third quarter results demonstrate the resilience and differentiated performance of our flavor-focused business model in a dynamic operating environment,” said Brendan M. Foley, Chairman, President, and CEO. “We delivered strong sales growth, including organic growth across our global flavor portfolio, while expanding our profit margins.” Read the release.
Conagra Brands, Inc. (NYSE: CAG) reported first quarter fiscal 2027 results, with net sales down 1.4% to $2.6 billion and organic net sales down 1.1%. Adjusted earnings per share rose 5.1% to $0.41, and the company reaffirmed its fiscal 2027 guidance, including an adjusted operating margin between 10.0% and 10.5% and adjusted EPS between $1.40 and $1.50. Conagra said it gained dollar share in categories including frozen vegetables, pudding and chili.
“We delivered a solid start to fiscal 2027 with top line results largely in line with expectations and profit ahead of expectations amid a challenging operating environment,” said John Brase, president and chief executive officer of Conagra Brands. Read the release.
WTW (Nasdaq: WTW) said its Willis business released the fall 2026 edition of its Insurance Marketplace Realities report, which found that large and complex commercial property rates fell an average of 14.5 percent in the second quarter of 2026, compared with 8.4 percent a year earlier. Shared and layered programs saw average declines of 23.41 percent, and the report said the market has moved toward pricing last seen in 2019.
“Property buyers have room to negotiate this cycle. Casualty and specialty buyers need to plan for a market that is still correcting for verdict severity and emerging technology risk,” said Jackie Bolig, Head of Placement and Broking Solutions for North America at Willis. Read the release.
RedHill Biopharma Ltd. (Nasdaq: RDHL) reported first half 2026 results and outlined a portfolio reset around two FDA-approved gastrointestinal brands. The company said it made a $12 million upfront payment to Ferring Pharmaceuticals for commercialization rights to Rebyota and Clenpiq, fully funded by the $18 million it received upfront for its Talicia divestment. RedHill said the two products generated approximately $37.5 million in 2025 net sales under Ferring.
“We have executed on two major transactions that unlock significant value and fuel our capacity for growth,” said Dror Ben-Asher, RedHill’s Chief Executive Officer. Read the release.
Recon Technology, Ltd (Nasdaq: RCON) reported fiscal 2026 results, with total revenue up 65.8% to RMB109.9 million ($16.2 million) and gross margin rising to 33.2% from 23.0%. The company said its net loss narrowed to RMB31.6 million ($4.7 million) from RMB43.7 million a year earlier, with overseas oilfield projects the primary growth driver.
Recon also marked the start of operations at its waste plastic chemical recycling plant in Weifang, Shandong Province, which it said is designed to process 40,000 tons of low-value waste plastics per year. “Fiscal 2026 marked a significant turning point for Recon,” said Shenping Yin, Founder and Chief Executive Officer. Read the release.
Contact Information:
Media Contact: info@stockpreachers.com
DISCLAIMER: Nothing in this article should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a market commentary and is not a paid advertisement. This article is being distributed by USA Newsroom, which is wholly owned and operated by Market Equities Limited (“MEL”), a company incorporated under the laws of Ireland. This is an independent market commentary published on a non-paid basis. MEL has not been paid any fee by any company mentioned in this article for its production or distribution, and MEL has no advertising or digital media agreement with any company mentioned in this article. The companies mentioned have not reviewed or approved this article. The Roadmap report referenced and linked in this article is published by Stock Preachers, which is also wholly owned and operated by MEL. Market Equities and its owners, operators, directors, and affiliates may, from time to time, hold positions in securities mentioned in this article or in the broad-market index funds that track them, and reserve the right to buy, sell, or hold such securities at any time without further notice. Information in this article was obtained from sources believed to be reliable, including company news releases and public market data, but its accuracy cannot be guaranteed. Market data is as of midday on the date stated and may be delayed. Investing in securities involves risk, including the possible loss of some or all of your investment. Technical analysis describes past price and volume behavior and does not predict future results; support and resistance levels can fail at any time. References to the companies named in this article are provided solely as market context and as summaries of each company’s own public news releases. No partnership, affiliation, or endorsement is implied, and nothing in this article is a recommendation to buy, sell, or hold any security. Quotations attributed to company executives are reproduced from those companies’ own news releases. This article may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including statements made by the companies mentioned in their own news releases, such as outlooks, guidance and preliminary unaudited results. Such statements involve risks and uncertainties, and actual results may differ materially. Readers should review each company’s filings with the SEC and applicable regulators. Eagle Eye is an investor signal-intelligence platform affiliated with the publisher of this article. Eagle Eye is not a broker-dealer, and nothing it provides is investment advice. Data may be delayed. Always do your own research.

